Oncocross Co., Ltd.

₩2,745As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:382150Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (42.57%)
Medical (Pharmaceuticals)
Beta (5Y) —
PE TTM —
TSR TTM (66.44%)
Mkt cap ₩35.81B
ROIC (30.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,870
4.57%
(99.25%)
Sell 1|4|1|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
35.24
35.20
35.87
35.63
17.22%
14.07%
13.84%
7.97%
Revenue₩B
1.730
1.757
1.763
1.820
12.64%
10.10%
4.68%
10.94%
Peers (US$26.40M)
Cap (US$)
PE
138.8M
—
45.64M
144.1x
19.91M
17.69x
Capital
TTM
5Y
10Y
Leveragex
1.830
0.234
0.212
EBIT/Intx
0.695
1.137
1.024
Own earn%
(15.03)
(6.61)
(3.22)
Sh yield%
31.69
24.29
23.16
Owners
Insiders/Inst%
7.61
66.58
Short interest%
0.87
SBC / revenue%
1.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
15–19
$1 testx
0.0
Incr. ROIC%
2